A pair of 'significant' findings from an otherwise inconclusive U.S. intelligence report on coronavirus origins


A review by the United States' intelligence community did not reach a firm conclusion on the origin of the coronavirus that sparked the COVID-19 pandemic, but it still may prove quite helpful moving forward.
While the report, ordered by President Biden earlier this year, determined only that both natural spillover from an infected animal and a lab leak were plausible theories as to how the pathogen jumped to humans, an unclassified summary of the report released Friday did show that there was broad agreement among the intelligence community on multiple areas, including that the virus was "not developed as a biological weapon" and that Chinese officials "did not have foreknowledge" of the virus ahead of the initial outbreak of COVID-19 in Wuhan, China, back in the fall of 2019.
Those don't provide a clear answer to the origin question, but they're still "significant," Robert Garry, a microbiologist at Tulane University School of Medicine, told NPR. He argued that if government officials didn't know about the coronavirus, then it's unlikely the Wuhan Institute of Virology — the lab most often associated with a potential lab leak — would have, either. "It's huge to mainly rule out that this is a product of engineering," Garry told Nature.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Per NPR, Garry thinks the report moves "the needle" toward "the natural origin" theory in that case. "I think you have to look at the scientific data that's out there," he said. "Follow the science, follow the animals." Read more at NPR and Nature.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Road trip: New England’s maple syrup season
Feature New England is serving up maple syrup in delicious and unexpected ways
By The Week US Published
-
Music Reviews: Mdou Moctar, Panda Bear, and Tate McRae
Feature “Tears of Injustice,” “Sinister Grift,” and “So Close to What”
By The Week US Published
-
What's at stake in the Mahmoud Khalil deportation fight?
Talking Points Vague accusations and First Amendment concerns
By Joel Mathis, The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published